Invention Grant
US09125861B2 PAR2 agonists for use in the treatment or prevention of influenza virus type A infections
有权
PAR2激动剂用于治疗或预防A型流感病毒感染
- Patent Title: PAR2 agonists for use in the treatment or prevention of influenza virus type A infections
- Patent Title (中): PAR2激动剂用于治疗或预防A型流感病毒感染
-
Application No.: US13266799Application Date: 2010-05-03
-
Publication No.: US09125861B2Publication Date: 2015-09-08
- Inventor: Nathalie Vergnolle , Beatrice Riteau
- Applicant: Nathalie Vergnolle , Beatrice Riteau
- Applicant Address: FR Paris FR Paris
- Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM),Institut National de la Recherche Agronomique (INRA)
- Current Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM),Institut National de la Recherche Agronomique (INRA)
- Current Assignee Address: FR Paris FR Paris
- Agency: Whitham Curtis Christofferson & Cook, PC
- Priority: EP09305393 20090504
- International Application: PCT/EP2010/055980 WO 20100503
- International Announcement: WO2010/128016 WO 20101111
- Main IPC: A61K38/08
- IPC: A61K38/08
Abstract:
Methods and compositions (such as pharmaceutical compositions) for treating influenza virus type A infections in human subjects include PAR2 agonists being administered to the subject. The PAR2 agonists include small organic molecules, antibodies, and aptamers. In addition, the PAR2 agonist may be a PAR2 activating peptide. Exemplary PAR2 activating peptides include SLIGRL (SEQ ID NO: 1) and SLIGKV (SEQ ID NO: 2).
Public/Granted literature
- US20120058127A1 PAR2 Agonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections Public/Granted day:2012-03-08
Information query
IPC分类:
